Patent · US Active

Prodrugs of clofarabine

US11021510B2 · kind B2 · utility

0Cited by
8References
11Claims
0Family size

Inventor

Key dates

Filing dateNov 1, 2017
Grant dateJun 1, 2021
Priority date
Expiry dateNov 1, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound useful for treating lymphoma, having the structure of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.